Vimarsana
Biggest News Aggregation in the World

Page 2 - Intersect Ent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intersect Ent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intersect Ent Today - Breaking & Trending Today

With the FTC's conditional approval, Medtronic completes its $1.1B acquisition of Intersect ENT - Vimarsana News

With the FTC's conditional approval, Medtronic completes its $1.1B acquisition of Intersect ENT

To get approval for the deal, Medtronic agreed to sell an Intersect subsidiary to soothe the FTC's concerns.

Intersect ENT, Inc. (NASDAQ:XENT) Short Interest Up 41.4% in April - Vimarsana News

Intersect ENT, Inc. (NASDAQ:XENT) Short Interest Up 41.4% in April

Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,870,000 shares, a growth of 41.4% from the March 31st total of 2,030,000 shares. Currently, 8.7% of the shares of the company are short […]

Calamos Advisors LLC Invests $5.53 Million in Intersect ENT, Inc. (NASDAQ:XENT) - Vimarsana News

Calamos Advisors LLC Invests $5.53 Million in Intersect ENT, Inc. (NASDAQ:XENT)

Calamos Advisors LLC purchased a new position in Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 202,386 shares of the medical equipment provider’s stock, valued at approximately $5,527,000. Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Two […]

StockNews.com Initiates Coverage on Intersect ENT (NASDAQ:XENT) - Vimarsana News

StockNews.com Initiates Coverage on Intersect ENT (NASDAQ:XENT)

StockNews.com assumed coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a report issued on Thursday. The brokerage issued a hold rating on the medical equipment provider’s stock. Shares of Intersect ENT stock opened at $27.75 on Thursday. The stock has a 50 day moving average of $27.46 and a 200 day moving […]

Brokerages Set Intersect ENT, Inc. (NASDAQ:XENT) Target Price at $25.95 - Vimarsana News

Brokerages Set Intersect ENT, Inc. (NASDAQ:XENT) Target Price at $25.95

Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) has been given a consensus recommendation of “Hold” by the six brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. The average 12-month price objective among brokers […]